Pharmacy defense expert witnesses

Pharmacy defense litigation presents fact patterns that are not intuitively accessible to lay jurors or, in many instances, to generalist counsel. The pharmacist's duty of care is defined by a combination of state pharmacy practice acts, board of pharmacy regulations, USP standards, and professional practice guidelines — a layered regulatory environment that requires informed interpretation. Without expert testimony, a defense theory that the pharmacy acted appropriately may rest entirely on cross-examination of the plaintiff's expert, which is a structurally weaker position.

A retained defense expert performs several functions simultaneously. First, the expert reviews the full dispensing record — including the original prescription, pharmacy management system logs, patient profile, and any documented counseling interactions — to assess whether each step in the dispensing process conformed to accepted practice. Second, the expert can identify documentation that plaintiff counsel may be mischaracterizing or missing context around, and prepare defense counsel to address those points in deposition and at trial. Third, an expert familiar with the specific pharmacy setting — whether a high-volume retail chain, an independent community pharmacy, a hospital inpatient pharmacy, or a specialty infusion pharmacy — can speak to the operational realities of that environment in a way that contextualizes the conduct without excusing it. This contextual grounding is often the difference between a verdict that reflects an informed evaluation of professional conduct and one that reflects an incomplete picture.

The appropriate expert specialty depends on the specific nature of the claim. The most common retained specialties in pharmacy defense matters include the following categories.

Community and retail pharmacy practice. Experts with direct experience in high-volume retail dispensing environments are appropriate where the claim involves a dispensing error, a counseling failure, or an automatic refill issue at a chain or independent pharmacy. These experts can speak to workflow pressures, verification protocols, and the pharmacist's role in catching prescribing errors before they reach the patient.

Clinical pharmacy and drug therapy management. When the claim involves a drug interaction, a contraindication that was not identified, or an issue with therapeutic appropriateness, a clinical pharmacist — particularly one with BPS certification in pharmacotherapy or a related discipline — may be better suited to address the clinical pharmacology underlying the harm alleged.

Hospital and health-system pharmacy. Inpatient dispensing claims, medication reconciliation failures, and automated dispensing cabinet errors require an expert familiar with the institutional pharmacy environment, including the pharmacist's role in multi-disciplinary care teams and the oversight responsibilities that accompany centralized dispensing systems.

Long-term care pharmacy. Claims arising from pharmacy services to nursing facilities or assisted living communities involve a distinct regulatory overlay, including consultant pharmacist obligations and facility-level medication management requirements, that differ materially from retail or hospital pharmacy practice.

Pharmacy informatics and operations. Where the claim involves pharmacy software, barcode scanning failures, electronic prescribing interface issues, or automated dispensing technology, an expert with pharmacy informatics or operations experience can address whether the technology was used in accordance with manufacturer guidance and professional standards, and whether the pharmacist's supervisory role was exercised appropriately.

Attorney reliance on an expert witness is only as sound as the verification behind the expert's credentials. For pharmacy defense profiles, the verification process addresses four primary areas.

First, licensure is confirmed. Each pharmacist expert's license is checked for active standing in their primary practice state, and any license restrictions, suspensions, or surrenders are documented. An expert who holds licensure in multiple states will have each license reviewed.

Second, board certification is confirmed directly against issuing-body records. BPS maintains a publicly searchable registry; claimed certifications in pharmacotherapy, ambulatory care, psychiatric pharmacy, nutrition support, oncology pharmacy, and other BPS disciplines are verified against that source before the credential is listed on a profile.

Third, prior disciplinary history at the state board level is reviewed. Consent orders, formal reprimands, civil monetary penalties, and other board actions are cross-referenced so that defense counsel is not caught off-guard when opposing counsel conducts its own background investigation.

Fourth, prior testimony history is documented to the extent available. The profile identifies whether the expert has given deposition testimony, trial testimony, or both, and whether prior engagements were predominantly defense-side or plaintiff-side. This information helps counsel calibrate how the expert is likely to perform under adversarial examination.

A well-structured pharmacy defense expert engagement proceeds through defined phases that map to litigation milestones. Understanding this arc helps counsel plan budgets and timelines more accurately.

In the initial phase, the expert conducts a preliminary record review based on materials provided by defense counsel — typically the prescription record, dispensing logs, patient profile, and any incident reports or complaint documentation. The expert provides an informal assessment of whether the standard-of-care issues raised by plaintiff's theory appear supportable on the available record. This is not a formal opinion and is typically protected work product, but it guides counsel's strategy and informs decisions about whether to retain this expert for the full matter.

In the report preparation phase, the expert reviews the complete case record, including plaintiff's expert report if one has been served, and produces a written report that identifies the applicable standard of care, evaluates the pharmacy's conduct against that standard, and sets out the expert's opinions with the basis for each. Defense counsel should expect to engage substantively in the drafting process to ensure that the report is responsive to the specific claims and does not create unnecessary exposure on cross-examination.

Deposition preparation is a critical phase that is often underresourced. The expert should be walked through plaintiff counsel's likely lines of attack, including challenges to the expert's qualifications, challenges to the methodology used to define the standard of care, and specific factual disputes in the record. An expert who has been thoroughly prepared is less likely to make concessions that undermine the defense theory.

At trial, pharmacy experts are most effective when their testimony is tightly scoped to the opinions in their report, when they can translate technical standards into plain language without losing precision, and when they are able to acknowledge reasonable limitations in their opinions without appearing evasive. Counsel should work with the expert before trial to identify the two or three core points the jury must take away from the testimony.

Expert testimony on the pharmacist's standard of care is subject to the same admissibility gatekeeping that applies in any professional liability matter. Under FRE 702 and the Daubert framework, a pharmacy expert's opinion must rest on sufficient facts or data, must be the product of reliable principles and methods, and must reflect a reliable application of those methods to the facts of the case. Defense counsel should be prepared to challenge plaintiff experts and to defend retained defense experts on each of these dimensions.

The most common methodological vulnerabilities in pharmacy standard-of-care opinions involve the source materials the expert used to define the standard. An expert who relies solely on package inserts, without reference to practice guidelines, board of pharmacy regulations, or peer-reviewed pharmacy practice literature, may be exposed on the question of whether the methodology is reliably grounded in the profession's actual standards. Conversely, a defense expert who draws on a broad and documented range of authoritative sources — state pharmacy practice acts, USP compounding standards, ASHP guidelines, BPS practice standards, and relevant peer-reviewed literature — presents a stronger methodological foundation that is more resistant to exclusion challenges.

Counsel should also evaluate whether the plaintiff expert's claimed qualifications match the specific pharmacy setting at issue. A clinical pharmacotherapy specialist opining on retail community pharmacy workflow practices, or a hospital inpatient pharmacist opining on long-term care consultant pharmacy obligations, may face a qualification challenge that defense counsel should preserve and develop through deposition before briefing a motion to exclude.

Understanding how plaintiff counsel is likely to frame a pharmacy negligence claim helps defense counsel structure the retained expert's testimony more precisely. Plaintiff theories in pharmacy cases generally fall into one of several patterns: the pharmacist failed to catch a prescribing error that a reasonably careful review would have identified; the pharmacist dispensed the wrong drug, dose, or dosage form; the pharmacist failed to counsel the patient about a known drug interaction or contraindication; or the pharmacy's systems, staffing, or workflow created conditions that made an error foreseeable and preventable.

Each of these theories has a corresponding defense framing. The pharmacist's duty to verify a prescription has defined limits — the pharmacist is not a co-prescriber, and there are categories of prescribing decisions that fall within the prescriber's exclusive authority. Dispensing errors must be evaluated in light of the verification systems actually in place, including barcode scanning, pharmacist final verification, and patient counseling at the point of pickup. Counseling obligations are shaped by patient response and documented refusals as well as by the regulatory baseline. And systemic claims about pharmacy workflow require evidence that the specific conditions alleged were present in the specific pharmacy at the specific time of the dispensing event, not that high-volume retail pharmacy in general presents risk.

A defense expert who is briefed on the plaintiff's specific theory — and who has reviewed the full record, not just selected excerpts — is better positioned to address each element of the plaintiff's framing directly, rather than offering a generalized defense of pharmacy practice that opposing counsel can characterize as non-responsive to the actual facts of the case.